Resources from the same session
Can we Stop Targeted Therapy, Immune or ADC Therapy?
Presenter: F. Schlürmann, FR
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast
Treatment after Progression on Adjuvant Therapy in Renal and Bladder Cancer
Presenter: A.Bex, NL
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Nausea and Ataxia in a Patient with Metastatic Clear Cell Renal Carcinoma: Not as Clear as it Seems
Presenter: D. Gómez, ES
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast
Participants Clinical Case Discussion: The Role of Cytoreductive Nephrectomy in the Era of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma
Presenter: N. Navarro, ES
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast
ADCs Present and Future in Bladder Cancer
Presenter: M. van der Heijden, NL
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast
Participants Clinical Case Discussion: Nephrectomy and Metastasectomy Post First Line Combination Immunotherapy for Metastatic Clear Cell RCC
Presenter: J. Allison, UK
Session: Session 6 - Focus on Toxicity and Duration of Therapy
Resources:
Slides
Webcast